This 2021 study investigates the impact of NAD⁺ boosting on age-related muscle degeneration. The research demonstrates that aging is associated with the accumulation of amyloid-like deposits and mitochondrial dysfunction in muscle tissues across species, including C. elegans, mice, and humans. Treatment with NAD⁺ precursors, such as nicotinamide riboside (NR) and
